- Home
- PCSA vs EZGO Comparison
PCSA vs EZGO Comparison
Compare PCSA & EZGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCSA
- EZGO
- Stock Information
- Founded
- PCSA 2011
- EZGO 2014
- Country
- PCSA United States
- EZGO China
- Employees
- PCSA N/A
- EZGO N/A
- Industry
- PCSA Biotechnology: Pharmaceutical Preparations
- EZGO Motor Vehicles
- Sector
- PCSA Health Care
- EZGO Consumer Discretionary
- Exchange
- PCSA Nasdaq
- EZGO Nasdaq
- Market Cap
- PCSA 2.8M
- EZGO 2.9M
- IPO Year
- PCSA N/A
- EZGO 2021
- Fundamental
- Price
- PCSA $0.45
- EZGO $0.40
- Analyst Decision
- PCSA Strong Buy
- EZGO
- Analyst Count
- PCSA 1
- EZGO 0
- Target Price
- PCSA $6.00
- EZGO N/A
- AVG Volume (30 Days)
- PCSA 105.2K
- EZGO 114.5K
- Earning Date
- PCSA 03-28-2025
- EZGO 03-25-2025
- Dividend Yield
- PCSA N/A
- EZGO N/A
- EPS Growth
- PCSA N/A
- EZGO N/A
- EPS
- PCSA N/A
- EZGO N/A
- Revenue
- PCSA N/A
- EZGO $21,134,425.00
- Revenue This Year
- PCSA N/A
- EZGO N/A
- Revenue Next Year
- PCSA N/A
- EZGO N/A
- P/E Ratio
- PCSA N/A
- EZGO N/A
- Revenue Growth
- PCSA N/A
- EZGO 32.75
- 52 Week Low
- PCSA $0.42
- EZGO $0.40
- 52 Week High
- PCSA $3.31
- EZGO $3.92
- Technical
- Relative Strength Index (RSI)
- PCSA 28.32
- EZGO 35.49
- Support Level
- PCSA $0.44
- EZGO $0.40
- Resistance Level
- PCSA $0.54
- EZGO $0.48
- Average True Range (ATR)
- PCSA 0.05
- EZGO 0.04
- MACD
- PCSA 0.00
- EZGO -0.00
- Stochastic Oscillator
- PCSA 16.03
- EZGO 0.15
About PCSA Processa Pharmaceuticals Inc.
Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its "regulatory science" approach in the development of Next Generation Chemotherapy ("NGC") oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small molecule oncology drugs. The NGC products are new chemical entities, but the company work by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The three NGC treatments in its pipeline are - NGC-Capecitabine (also referred to as NGC-Cap), PCS3117, also referred to as NGC-Gemcitabine (NGC-Gem), PCS11T, also referred to as NGC-Irinotecan (NGC-Iri).
About EZGO EZGO Technologies Ltd.
EZGO Technologies Ltd is engaged in the sale of e-bicycles and battery and e-bicycle rentals, complemented by the sale of battery packs, battery cell trading and charging pile business. Its product categories include e-bicycle, Intelligent unmanned patrol car, e-motorcycle and e-moped and urban style e-tricycle. Its segments include the Battery cells and packs, electronic control system and intelligent robot segment. and the E-bicycle sales segment. The company generates maximum revenue from the Battery cells and packs segment.